Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Case-Based fMRI Analysis after Cognitive Rehabilitation in MS: A Novel Approach.
Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia.
Incidence of Multiple Sclerosis and Related Disorders in Asian Populations of British Columbia.
Safety of TNF inhibitors in adolescents and children.
Anesthesia for the obstetric patient with multiple sclerosis.
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model.
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection.
Evaluating the Role of Coping Style as a Moderator of Fatigue and Risk for Future Cognitive Impairment in Multiple Sclerosis.
The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.
Genomic Binding Sites and Biological Effects of the Vitamin D: VDR Complex in Multiple Sclerosis.
Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome.
Trigeminal neuralgia: a condition to be better understood.
Genetic proof for the transient nature of the Th17 phenotype.
Myelin organization in the nodal, paranodal, and juxtaparanodal regions revealed by scanning x-ray microdiffraction.
Distribution of axon diameters in cortical white matter: an electron-microscopic study on three human brains and a macaque.
Distilling the essence of appraisal: a mixed methods study of people with multiple sclerosis.
Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
Natalizumab: Bench to Bedside and Beyond.
Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.
Pro-Inflammatory Cytokines Reduce the Proliferation of NG2 Cells and Increase Shedding of NG2 In Vivo and In Vitro.
The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: Interleukin-17A and interleukin-17F serum levels.
Promotion of experimental autoimmune encephalomyelitis upon neutrophil granulocytes' stimulation with formyl-methionyl-leucyl-phenylalanine (fMLP) peptide.
Therapeutic potential of cannabinoid medicines.
Apparent Diffusion Coefficient Histograms in the Follow-up of Relapsing-Remitting Multiple Sclerosis.

Pages